MassDevice.com +5 | The top 5 medtech stories for September 12, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Here’s how GE wants to make anesthesia machines smarter GE officials think their Mini Field Agent – a plug-and-play connectivity device used in many industries – could enable smarter use of anesthesia machines and other medical devices. The Boston-based conglomerate is in the process of rolling out the Field Agent to health providers. About 10 health provider customers are already using the Mini Field Agent for anesthesia machines; the goal is for about 100 customers to use it by next year. Read more 4. Neovasc shares rise on Tiara transcath mitral valve trial update Neovasc today updated on the clincial study of its Tiara self-expanding transcatheter mitral valve bioprosthesis designed to treat mitral regurgitation, touting 31 successful implants and a 12.1% rate of 30-day mortality. The Vancouver-based company said that to date 34 patients have been treated with the Tiara at 10 centers globally, with a technical implantation success rate of 91.1%. Read more 3. Appeals court shoots down Synthes bid to unseal grand jury records in Norian bone cement trial Joh...
Source: Mass Device - Category: Medical Devices Authors: Tags: News Well Plus 5 Source Type: news